Penkowa M - Search Results

1

Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.

Penkowa M, Camats J, Hadberg H, Quintana A, Rojas S, Giralt M, Molinero A, Campbell IL, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2003 Aug 15;73(4):481-96. doi: 10.1002/jnr.10681. J Neurosci Res. 2003. PMID: 12898533

2

Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.

Penkowa M, Giralt M, Camats J, Hidalgo J. Penkowa M, et al. J Comp Neurol. 2002 Mar 5;444(2):174-89. doi: 10.1002/cne.10149. J Comp Neurol. 2002. PMID: 11835189

3

M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.

Penkowa M, Poulsen C, Carrasco J, Hidalgo J. Penkowa M, et al. Exp Neurol. 2002 Aug;176(2):308-21. doi: 10.1006/exnr.2002.7968. Exp Neurol. 2002. Retraction in: Exp Neurol. 2013 Sep;247:755. doi: 10.1016/j.expneurol.2013.02.015 PMID: 12359172 Retracted.

4

Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.

Penkowa M, Camats J, Giralt M, Molinero A, Hernández J, Carrasco J, Campbell IL, Hidalgo J. Penkowa M, et al. Glia. 2003 May;42(3):287-306. doi: 10.1002/glia.10208. Glia. 2003. PMID: 12673834

5

Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis.

Penkowa M, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2003 Jun 1;72(5):574-86. doi: 10.1002/jnr.10615. J Neurosci Res. 2003. Retraction in: J Neurosci Res. 2019 May;97(5):639. doi: 10.1002/jnr.24407 PMID: 12749022 Retracted.

6

Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.

Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J, Molinero A, Campbell IL, Hidalgo J. Penkowa M, et al. Exp Neurol. 2003 Jun;181(2):130-48. doi: 10.1016/s0014-4886(02)00051-1. Exp Neurol. 2003. PMID: 12781987

7

Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.

Penkowa M, Quintana A, Carrasco J, Giralt M, Molinero A, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2004 Jul 1;77(1):35-53. doi: 10.1002/jnr.20154. J Neurosci Res. 2004. PMID: 15197737

8

Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.

Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2005 Feb 15;79(4):522-34. doi: 10.1002/jnr.20387. J Neurosci Res. 2005. PMID: 15614785

9

Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury.

Quintana A, Giralt M, Rojas S, Penkowa M, Campbell IL, Hidalgo J, Molinero A. Quintana A, et al. Among authors: penkowa m. J Neurosci Res. 2005 Dec 1;82(5):701-16. doi: 10.1002/jnr.20680. J Neurosci Res. 2005. PMID: 16267827

10

Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.

Penkowa M, Tio L, Giralt M, Quintana A, Molinero A, Atrian S, Vasák M, Hidalgo J. Penkowa M, et al. J Neurosci Res. 2006 May 1;83(6):974-84. doi: 10.1002/jnr.20790. J Neurosci Res. 2006. PMID: 16493670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters